Free Trial

BIOLASE (BIOL) Competitors

BIOLASE logo
$0.0010 0.00 (0.00%)
As of 07/23/2025

BIOL vs. DYNT, NUWE, NAYA, SONX, IONM, HSDT, AFIB, BRSH, SDCCQ, and GMVDF

Should you be buying BIOLASE stock or one of its competitors? The main competitors of BIOLASE include Dynatronics (DYNT), Nuwellis (NUWE), NAYA Biosciences (NAYA), Sonendo (SONX), Assure (IONM), Helius Medical Technologies (HSDT), Acutus Medical (AFIB), Bruush Oral Care (BRSH), SmileDirectClub (SDCCQ), and G Medical Innovations (GMVDF). These companies are all part of the "medical equipment" industry.

BIOLASE vs. Its Competitors

BIOLASE (NASDAQ:BIOL) and Dynatronics (NASDAQ:DYNT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

Dynatronics has lower revenue, but higher earnings than BIOLASE. Dynatronics is trading at a lower price-to-earnings ratio than BIOLASE, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIOLASE$48.83M0.00-$20.63M-$14.940.00
Dynatronics$33.60M0.04-$2.70M-$0.78-0.12

BIOLASE has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500.

8.8% of BIOLASE shares are held by institutional investors. Comparatively, 4.2% of Dynatronics shares are held by institutional investors. 0.3% of BIOLASE shares are held by company insiders. Comparatively, 8.0% of Dynatronics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, BIOLASE's average media sentiment score of 0.00 equaled Dynatronics'average media sentiment score.

Company Overall Sentiment
BIOLASE Neutral
Dynatronics Neutral

BIOLASE currently has a consensus target price of $1.20, suggesting a potential upside of 119,900.00%. Given BIOLASE's stronger consensus rating and higher possible upside, analysts plainly believe BIOLASE is more favorable than Dynatronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIOLASE
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Dynatronics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Dynatronics has a net margin of -8.35% compared to BIOLASE's net margin of -41.65%. Dynatronics' return on equity of -41.81% beat BIOLASE's return on equity.

Company Net Margins Return on Equity Return on Assets
BIOLASE-41.65% -1,782.73% -55.31%
Dynatronics -8.35%-41.81%-9.56%

Summary

BIOLASE and Dynatronics tied by winning 7 of the 14 factors compared between the two stocks.

Get BIOLASE News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIOL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIOL vs. The Competition

MetricBIOLASEDental equipment & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$33K$263K$5.70B$9.48B
Dividend YieldN/AN/A4.59%3.99%
P/E Ratio0.00N/A27.9019.95
Price / Sales0.000.01442.19102.72
Price / CashN/AN/A36.5558.97
Price / Book-0.010.018.635.90
Net Income-$20.63M-$40.78M$3.24B$258.42M
7 Day PerformanceN/AN/A3.22%1.94%
1 Month PerformanceN/AN/A10.72%12.02%
1 Year PerformanceN/AN/A34.94%20.81%

BIOLASE Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIOL
BIOLASE
1.0847 of 5 stars
$0.00
flat
$1.20
+119,900.0%
-98.7%$33K$48.83M0.00160
DYNT
Dynatronics
N/A$0.09
-7.4%
N/A-71.0%$935K$33.60M-0.11200Gap Down
NUWE
Nuwellis
3.0423 of 5 stars
$7.81
+13.5%
$714.00
+9,042.1%
-92.1%$812K$8.79M-0.0170News Coverage
High Trading Volume
NAYA
NAYA Biosciences
N/A$0.78
-5.4%
$24.00
+2,993.6%
N/A$517K$6.23M0.0010High Trading Volume
SONX
Sonendo
N/A$1.15
flat
N/A+1,508.4%$493K$44.40M-0.02250
IONM
Assure
N/A$0.03
flat
N/A-98.0%$91K$149K0.00130Gap Up
HSDT
Helius Medical Technologies
0.439 of 5 stars
$7.35
-8.7%
N/A-98.7%$74K$520K0.0030High Trading Volume
AFIB
Acutus Medical
N/A$0.00
+10.0%
N/A-99.5%$66K$7.16M0.00340Gap Down
BRSH
Bruush Oral Care
N/AN/AN/AN/A$44K$2.92M0.0011Gap Down
SDCCQ
SmileDirectClub
N/AN/AN/A-96.4%$40K$470.74M0.002,700Gap Down
GMVDF
G Medical Innovations
N/A$0.00
flat
N/AN/A$26K$4.42M0.0072

Related Companies and Tools


This page (NASDAQ:BIOL) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners